Literature DB >> 21063835

Inhibitive effect of cremophor RH40 or tween 80-based self-microemulsiflying drug delivery system on cytochrome P450 3A enzymes in murine hepatocytes.

Zichao Rao1, Luqin Si, Yanbin Guan, Hongping Pan, Jun Qiu, Gao Li.   

Abstract

This study examined the effect of self-microemulsiflying drug delivery system (SMEDDS) containing Cremophor RH40 or Tween 80 at various dilutions on cytochrome P450 3A (CYP3A) enzymes in rat hepatocytes, with midazolam serving as a CYP3A substrate. The particle size and zeta potential of microemulsions were evaluated upon dilution with aqueous medium. In vitro release was detected by a dialysis method in reverse. The effects of SMEDDS at different dilutions and surfactants at different concentrations on the metabolism of MDZ were investigated in murine hepatocytes. The cytotoxicity of SMEDDS at different dilutions was measured by LDH release and MTT technique. The effects of SMEDDS on the CYP3A enzymes activity were determined by Western blotting. Our results showed that dilution had less effect on the particle size and zeta potential in the range from 1:25 to 1:500. The MDZ was completely released in 10 h. A significant decrease in the formation of 1'-OH-MDZ in rat hepatocytes was observed after treatment with both SMEDDS at dilutions ranging from 1:50 to 1:250 and Cremophor RH 40 or Tween 80 at concentrations ranging from 0.1% to 1% (w/v), with no cytotoxicity observed. A significant decrease in CYP3A protein expression was observed in cells by Western blotting in the presence of either Cremophor RH40 or Tween 80-based SMEDDS at the dilutions ranging from 1:50 to 1:250. This study suggested that the excipient inhibitor-based formulation is a potential protective platform for decreasing metabolism of sensitive drugs that are CYP3A substrates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063835     DOI: 10.1007/s11596-010-0543-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  34 in total

1.  Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.

Authors:  Kiyomi Ito; J Brian Houston
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

Review 2.  Structural basis of selective cytochrome P450 inhibition.

Authors:  J R Halpert
Journal:  Annu Rev Pharmacol Toxicol       Date:  1995       Impact factor: 13.820

3.  Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone.

Authors:  T Gershanik; S Benita
Journal:  Pharm Dev Technol       Date:  1996-07       Impact factor: 3.133

4.  Refinement of an in vitro cell model for cytochrome P450 induction.

Authors:  J M Silva; P E Morin; S H Day; B P Kennedy; P Payette; T Rushmore; J A Yergey; D A Nicoll-Griffith
Journal:  Drug Metab Dispos       Date:  1998-05       Impact factor: 3.922

Review 5.  Nuclear receptors and lipid physiology: opening the X-files.

Authors:  A Chawla; J J Repa; R M Evans; D J Mangelsdorf
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

6.  Evaluation of absorption enhancement for a potent cyclopeptidic alpha(nu)beta(3)-antagonist in a human intestinal cell line (Caco-2).

Authors:  W Kamm; A Jonczyk; T Jung; G Luckenbach; P Raddatz; T Kissel
Journal:  Eur J Pharm Sci       Date:  2000-05       Impact factor: 4.384

7.  The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.

Authors:  Sunil Jambhekar; R Casella; T Maher
Journal:  Int J Pharm       Date:  2004-02-11       Impact factor: 5.875

8.  Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2.

Authors:  Qin Mei; Karen Richards; Kristie Strong-Basalyga; Scott E Fauty; Anne Taylor; Masayo Yamazaki; Thomayant Prueksaritanont; Jiunn H Lin; Jerome Hochman
Journal:  J Pharm Sci       Date:  2004-10       Impact factor: 3.534

Review 9.  The safety of pharmaceutical excipients.

Authors:  Giorgio Pifferi; Patrizia Restani
Journal:  Farmaco       Date:  2003-08

10.  Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.

Authors:  Angie L Bookout; Yangsik Jeong; Michael Downes; Ruth T Yu; Ronald M Evans; David J Mangelsdorf
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

View more
  4 in total

Review 1.  Impact of excipient interactions on drug bioavailability from solid dosage forms.

Authors:  Ravikiran Panakanti; Ajit S Narang
Journal:  Pharm Res       Date:  2012-05-19       Impact factor: 4.200

2.  Novel cationic supersaturable nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes.

Authors:  Atul Jain; Rajpreet Kaur; Sarwar Beg; Varun Kushwah; Sanyog Jain; Bhupinder Singh
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

3.  Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies.

Authors:  Yosra S R Elnaggar; Samar M Etman; Doaa A Abdelmonsif; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2015-08-27

Review 4.  Pharmaceutical Excipients and Drug Metabolism: A Mini-Review.

Authors:  Rahul Patel; James Barker; Amr ElShaer
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.